Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
B-Cell Depletion by Anti-CD20 (Rituximab) in Renal Allograft Recipients Who Develop De Novo Anti-HLA Alloantibodies will Result in Inhibition of Alloantibody Production and Attenuation of Chronic Humoral Rejection (CTOT-02/CCTPT-02)
Grant
Overview
Affiliation
Overview
Awarded By
Brigham and Women's Hospital
Total Award Amount
260250.00
Direct Costs
191897.00
Sponsor Award Id
Affiliation
Contributor
Vineeta Kumar
Principal Investigator